Mendelson W B
Department of Neurology, Cleveland Clinic Foundation, Ohio, USA.
Sleep. 1995 Feb;18(2):92-6. doi: 10.1093/sleep/18.2.92.
We have shown previously that the benzodiazepine hypnotic triazolam alters the perception of being awake or asleep in insomniacs, making it more likely that they will report having been asleep when awakened by an electronic tone at various times of the night. In the present study, we examined the question as to whether this is also true for other benzodiazepines as well as for nonbenzodiazepine hypnotics. Ten insomniacs were given placebo, flurazepam 30 mg and zolpidem 10 mg and were awakened at five times during subsequent sleep in a random-sequence repeated-measures study. Across all five awakenings following placebo, insomniacs reported being asleep with a frequency of 30.9%. This rose to 40.4% (ns) and 54.7% (p < 0.03) on flurazepam and zolpidem, respectively. Subjects were also more likely to report having been dreaming during the awakening 5 minutes after "lights out" after receiving zolpidem. A number of polygraphic measures of sleep, including sleep latency, total sleep and sleep efficiency, improved significantly on both drugs, and there was similar improvement in some global measures of quality of sleep. Neither drug altered the subjective sense of duration of time. These findings suggest that drug-induced alterations in the perception of being awake or asleep are not unique to benzodiazepines, but occur with the nonbenzodiazepine zolpidem as well.
我们之前已经表明,苯二氮䓬类催眠药三唑仑会改变失眠者对清醒或睡眠的感知,使得他们在夜间不同时间被电子音唤醒时更有可能报告自己处于睡眠状态。在本研究中,我们探讨了对于其他苯二氮䓬类药物以及非苯二氮䓬类催眠药而言,情况是否也是如此。在一项随机序列重复测量研究中,10名失眠者被给予安慰剂、30毫克氟西泮和10毫克唑吡坦,随后在睡眠期间被唤醒5次。在服用安慰剂后的所有5次唤醒中,失眠者报告处于睡眠状态的频率为30.9%。服用氟西泮和唑吡坦后,这一频率分别升至40.4%(无显著差异)和54.7%(p<0.03)。服用唑吡坦后,受试者在“熄灯”后5分钟被唤醒时也更有可能报告自己在做梦。包括睡眠潜伏期、总睡眠时间和睡眠效率在内的多项睡眠多导测量指标在两种药物治疗后均有显著改善,一些整体睡眠质量指标也有类似改善。两种药物均未改变主观时间持续感。这些发现表明,药物引起的对清醒或睡眠的感知改变并非苯二氮䓬类药物所特有,非苯二氮䓬类药物唑吡坦也会出现这种情况。